Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor
FDA ADHD Stimulant Label Change: Weight Loss Risk PMHNPs Must Know
The FDA has updated its labeling for extended-release ADHD stimulants to include a warning about potential weight loss risk in children under 6. Nurse practitioners should implement monitoring protocols for weight changes and consider formulation differences.